Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Prevalence of inherited neurotransmitter disorders in patients with movement disorders and epilepsy: a retrospective cohort study.

Mercimek-Mahmutoglu S, Sidky S, Hyland K, Patel J, Donner EJ, Logan W, Mendoza-Londono R, Moharir M, Raiman J, Schulze A, Siriwardena K, Yoon G, Kyriakopoulou L.

Orphanet J Rare Dis. 2015 Feb 8;10:12. doi: 10.1186/s13023-015-0234-9.

2.
3.

Clinical spectrum of dopa-responsive dystonia and related disorders.

Lee WW, Jeon BS.

Curr Neurol Neurosci Rep. 2014 Jul;14(7):461. doi: 10.1007/s11910-014-0461-9. Review.

4.

Asymmetrical leg atrophy in levodopa-responsive dystonia due to a novel GTP cyclohydrolase mutation.

Mulroy E, McCarthy A, Lynch T, Costello D, Ross OA.

Mov Disord. 2014 Mar;29(3):425-6. doi: 10.1002/mds.25813. No abstract available.

5.

Recent advances in the molecular pathogenesis of dystonia-plus syndromes and heredodegenerative dystonias.

Casper C, Kalliolia E, Warner TT.

Curr Neuropharmacol. 2013 Jan;11(1):30-40. doi: 10.2174/157015913804999432.

6.

The genetics of dystonia: new twists in an old tale.

Charlesworth G, Bhatia KP, Wood NW.

Brain. 2013 Jul;136(Pt 7):2017-37. doi: 10.1093/brain/awt138. Review.

7.

GTP cyclohydrolase I and tyrosine hydroxylase gene mutations in familial and sporadic dopa-responsive dystonia patients.

Cai C, Shi W, Zeng Z, Zhang M, Ling C, Chen L, Cai C, Zhang B, Li WD.

PLoS One. 2013 Jun 6;8(6):e65215. doi: 10.1371/journal.pone.0065215.

8.

Paroxysmal Kinesigenic Dyskinesia-like Symptoms in a Patient with Tourette Syndrome.

Oyama G, Okun MS, Ashizawa T, Malaty IA.

Tremor Other Hyperkinet Mov (N Y). 2011;1. pii: tre-01-31-157-1. doi: 10.7916/D8XG9PWK.

9.

Guanine triphosphate-cyclohydrolase 1-deficient dopa-responsive dystonia presenting as frequent falling in 2 children.

Tsao CY.

J Child Neurol. 2012 Mar;27(3):389-91. doi: 10.1177/0883073811420871. Review.

10.

Nonmotor manifestations of dystonia: a systematic review.

Kuyper DJ, Parra V, Aerts S, Okun MS, Kluger BM.

Mov Disord. 2011 Jun;26(7):1206-17. doi: 10.1002/mds.23709. Review.

11.

Sleep and rhythm consequences of a genetically induced loss of serotonin.

Leu-Semenescu S, Arnulf I, Decaix C, Moussa F, Clot F, Boniol C, Touitou Y, Levy R, Vidailhet M, Roze E.

Sleep. 2010 Mar;33(3):307-14.

12.

Commentary: Dopaminergic dysfunction in DYT1 dystonia.

Wichmann T.

Exp Neurol. 2008 Aug;212(2):242-6. doi: 10.1016/j.expneurol.2008.04.020. Review.

13.

Study of a Swiss dopa-responsive dystonia family with a deletion in GCH1: redefining DYT14 as DYT5.

Wider C, Melquist S, Hauf M, Solida A, Cobb SA, Kachergus JM, Gass J, Coon KD, Baker M, Cannon A, Stephan DA, Schorderet DF, Ghika J, Burkhard PR, Kapatos G, Hutton M, Farrer MJ, Wszolek ZK, Vingerhoets FJ.

Neurology. 2008 Apr 15;70(16 Pt 2):1377-83.

14.

Co-occurrence of affective and schizophrenia spectrum disorders with PINK1 mutations.

Steinlechner S, Stahlberg J, Völkel B, Djarmati A, Hagenah J, Hiller A, Hedrich K, König I, Klein C, Lencer R.

J Neurol Neurosurg Psychiatry. 2007 May;78(5):532-5.

Items per page

Supplemental Content

Support Center